LC–MS/MS Assays to Quantify Sulfatides and Lysosulfatide in Cerebrospinal Fluid of Metachromatic Leukodystrophy Patients

Karen (Hongmei) Cao1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USA;3 Present address: Alnylam Pharmaceuticals, 300 Third Street, Cambridge, MA02142, USACorrespondence[email protected]
View further author information

Guodong Zhang1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USA;3 Present address: Alnylam Pharmaceuticals, 300 Third Street, Cambridge, MA02142, USAView further author information

Leslie Jacobsen2 Shire, a member of The Takeda Group of Companies, 300 Shire Way, Lexington, MA02421, USA;4 Present address: AVROBIO, One Kendall Square, Building 300, Suite 201, Cambridge, MA02139, USAView further author information

Jiang Wu1 Shire, a member of The Takeda Group of Companies, 125 Binney Street, Cambridge, MA02142, USACorrespondence[email protected]

https://orcid.org/0000-0002-6445-8788 View further author information

LC–MS/MS Assays to Quantify Sulfatides and Lysosulfatide in Cerebrospinal Fluid of Metachromatic Leukodystrophy Patients

Supplemental Material

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

LC–MS/MS Assays to Quantify Sulfatides and Lysosulfatide in Cerebrospinal Fluid of Metachromatic Leukodystrophy Patients

Supplemental Material

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date